Better half worked on the approval of J&J #icotrokinra. Happy birthday to Icotyde! My 11 year old made this card! #psoriasis #medicine #drugs #chemistry #IL23

J&J gets FDA okay for psoriasis drug icotrokinra Johnson & Johnson's much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.

#JohnsonandJohnson's much-anticipated oral IL-23 inhibitor, #icotrokinra, has claimed #FDAapproval as a first-line treatment for #plaquepsoriasis.

Icotrokinra Shows Promising Results in Treating Ulcerative Colitis Over 28 Weeks Icotrokinra, a novel oral therapy, has shown significant efficacy in patients with ulcerative colitis, sustaining treatment benefits through 28 weeks of use.

Icotrokinra Shows Promising Results in Treating Ulcerative Colitis Over 28 Weeks #United_States #Ulcerative_Colitis #Johnson_&_Johnson #Phoenix #Icotrokinra

Long-term Results for Icotrokinra Show Promise in Clearing Psoriasis New long-term results from the Phase 3 ICONIC-TOTAL study reveal that Icotrokinra offers significant skin clearance and safety for psoriasis patients.

Long-term Results for Icotrokinra Show Promise in Clearing Psoriasis #USA #Johnson_&_Johnson #Spring_House #Psoriasis #Icotrokinra

Icotrokinra: A Promising New Treatment for Ulcerative Colitis Icotrokinra demonstrates significant therapeutic benefits and safety for ulcerative colitis patients, as seen in recent clinical trials. The once-daily pill showed impressive clinical response rates and remission improvements.

Icotrokinra: A Promising New Treatment for Ulcerative Colitis #United_States #Ulcerative_Colitis #Johnson_&_Johnson #Spring_House #Icotrokinra

Icotrokinra Outshines Deucravacitinib in Head-to-Head Phase 3 Trials for Plaque Psoriasis Treatment Recent Phase 3 trials reveal Icotrokinra's effectiveness over Deucravacitinib for treating moderate-to-severe plaque psoriasis, promising a new oral peptide treatment option.

Icotrokinra Outshines Deucravacitinib in Head-to-Head Phase 3 Trials for Plaque Psoriasis Treatment #USA #Spring_House #Psoriasis #Icotrokinra #Deucravacitinib

Johnson & Johnson Files for ICOTROKINRA FDA Approval, Pioneering Psoriasis Treatment for All Ages Johnson & Johnson aims to change psoriasis treatment with icotrokinra, an oral peptide that targets IL-23 receptors, offering hope for patients aged 12 and older.

Johnson & Johnson Files for ICOTROKINRA FDA Approval, Pioneering Psoriasis Treatment for All Ages #USA #Johnson_&_Johnson #Spring_House #Psoriasis #Icotrokinra

Icotrokinra Shows Promising Results in Treating Scalp and Genital Psoriasis New findings from a Phase 3 study reveal that icotrokinra significantly improves skin conditions for patients suffering from psoriasis in hard-to-treat areas.

Icotrokinra Shows Promising Results in Treating Scalp and Genital Psoriasis #USA #Johnson_&_Johnson #Spring_House #Psoriasis #Icotrokinra

Promising Results of Icotrokinra in Treating Adolescents with Plaque Psoriasis Johnson & Johnson's recent study shows Icotrokinra's effectiveness in treating plaque psoriasis in teenagers, achieving clear skin for 75% of participants.

Promising Results of Icotrokinra in Treating Adolescents with Plaque Psoriasis #United_States #Johnson_&_Johnson #Spring_House #Icotrokinra #Plaque_Psoriasis

Some amazing new data presented at #AAD2025. A new #Tyk2 hits #PASI100 in 50% of patients, #Deucravacitinib offers new hope for patients with #lupus and astounding safety and efficacy of #Icotrokinra for #psoriasis.

Details at: www.healio.com/news/dermato...
#DermSky #RheumSky

Icotrokinra Proves Effective in Ulcerative Colitis Trial, Paving Way for New Treatment Approaches Johnson & Johnson's icotrokinra shows significant potential to improve clinical responses in ulcerative colitis, marking a possible shift in treatment strategies for patients.

Icotrokinra Proves Effective in Ulcerative Colitis Trial, Paving Way for New Treatment Approaches #United_States #Ulcerative_Colitis #Johnson_&_Johnson #Spring_House #Icotrokinra

Icotrokinra Emerges as a Game-Changer in Plaque Psoriasis Treatment New findings on icotrokinra reveal its potential to redefine treatment for plaque psoriasis, showcasing impressive skin clearance and safety in a daily oral form.

Icotrokinra Emerges as a Game-Changer in Plaque Psoriasis Treatment #United_States #Johnson_&_Johnson #Spring_House #Icotrokinra #Plaque_Psoriasis